ENTITY
111 Inc

111 Inc (YI US)

121
Analysis
Information TechnologyChina
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
bearishTencent
20 Oct 2018 19:18

Last Week in GER Research: Tencent Backed IPOs, Niu, Innovent Biologics, Babytree and Fujifilm

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight a very differentiated...

Logo
661 Views
Share
bullishTencent Music
06 Oct 2018 15:41

ECM Weekly (6 October 2018) - Tencent Music, Aston Martin, Osotspa, China Renaissance

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
02 Oct 2018 06:08

Last Week in GER Research: Haidilao, Popflops, Bitmain, Shandong Gold, Niu and China Renaissance

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight 25% potential downside at Haidilao as...

Logo
397 Views
Share
bearishMeituan
24 Sep 2018 06:21

Last Week in GER Research: Meituan, IPO Trading Strategy, Shandong Gold, Maoyan and Viomi

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight that Meituan is closer to fair value...

Logo
336 Views
Share
bearish111 Inc
18 Sep 2018 16:03

111 Inc. (1药网) Trading Update - No Changes to Assumptions; Fairly Valued at Best

111 Inc (YI US) 's debut performance was a stark contrast to NIO Inc (NIO US) despite both pricing at the low end. 111, however, had to downsize...

Share
x